Search results
Results from the WOW.Com Content Network
LivaNova, plc is an Italian-American medical device manufacturer based in the UK. The company develops devices used for cardiac surgery and neuromodulation.The company was formed in 2015 by a $2.7B merger between Houston, Texas-based Cyberonics, Inc. and Milan, Italy-based Sorin S.p.a. [2] The company trades on the NASDAQ stock exchange under the ticker symbol "LIVN".
The Board voted to authorize an agreement with Heart Technologies for an amount not to exceed $298,535. The purchase will necessitate a budget transfer from the General Fund contingency account to ...
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. [4]
Cardiac Pacemakers, Inc. (CPI), doing business as Guidant Cardiac Rhythm Management, manufactured implantable cardiac rhythm management devices, such as pacemakers and defibrillators. It sold microprocessor-controlled insulin pumps and equipment to regulate heart rhythm.
The company develops mobile to cloud-based health technologies for smartphone, tablets, and the web.Through collaborations with Merck, Mayo Clinic, and Pfizer the company has released close to 40 applications for prescription medication management, cardiac care, sleep apnea, and diabetes management.
A new type of internal heart defibrillator, implanted for the first time in Michigan at Sparrow Hospital, could help younger patients live longer. ... of course it is a new technology and as time ...
The HeartAssist5 is a modern version of the DeBakey VAD [10] and as of December 2014 was the only remotely monitored medical device in the world. [8] It was first approved for use in Europe in 2009 under MicroMed Cardiovascular, Inc. [11] The HeartAssist5 is in use in Europe [10] as a destination therapy by patients who are not candidates to receive heart transplants and as a bridge to ...
Featuring the company's advanced algorithm - SmartGuard technology and glucose sensor - Guardian™ Sensor 3, it was the first insulin pump approved by the Food and Drug Administration (FDA) that enabled personalized and automated* delivery of basal insulin, the background insulin needed to maintain stable blood sugar levels throughout the day ...